Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
EMA safety_alert · 2018-07-27EMA restricts use of prostate cancer medicine Xofigo
The EMA restricts the use of Xofigo (radium-223 dichloride) for prostate cancer due to safety concerns and updated recommendations.
-
EMA safety_alert · 2018-03-09Prostate cancer medicine Xofigo must not be used with Zytiga and prednisone/prednisolone
Regulatory communication advising that the prostate cancer medicine Xofigo should not be used with Zytiga (abiraterone) and prednisone/predn…
-
CLINICAL_TRIALS safety_alert · 2009-02-24Clinical Trial Update: GVAX in Advanced Prostate Cancer Patients Made Lymphopenic [Phase 1, Phase 2]
This Phase 1/2 trial update of GVAX in advanced prostate cancer notes that patients became lymphopenic, indicating a potential safety concer…